Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 22-Nov-22 4:07 PM View:  | Theravance Biopharma, Inc. (TBPH) | 20-Nov-22 | Payment of Exercise | 25,057 | $10.85 | $271,868.00 | (6%) 409.77K to 384.71K | |
| 22-Nov-22 4:07 PM View: | Theravance Biopharma, Inc. (TBPH) | 18-Nov-22 | Private Sale | 65,000 | $11.02 | $716,242.00 | (14%) 474.77K to 409.77K | |
| 23-Aug-22 7:00 PM View: | Theravance Biopharma, Inc. (TBPH) | 19-Aug-22 | Payment of Exercise | 25,676 | $9.34 | $239,814.00 | (5%) 499.18K to 473.51K | (4%) |
| 27-Jul-22 6:56 PM View: | Theravance Biopharma, Inc. (TBPH) | 25-Jul-22 | Grant | 20,000 | -- | -- | 4% 479.18K to 499.18K | |
| 24-May-22 7:17 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-May-22 | Payment of Exercise | 3,365 | $8.74 | $29,410.10 | (< 1%) 482.55K to 479.18K | (11%) |
| 23-Feb-22 6:29 PM View: | Theravance Biopharma, Inc. (TBPH) | 18-Feb-22 | Payment of Exercise | 25,973 | $9.61 | $249,601.00 | (5%) 507.26K to 481.29K | (1%) |
| 06-Dec-21 7:53 PM View: | Theravance Biopharma, Inc. (TBPH) | 02-Dec-21 | Grant | 340,000 | -- | -- | 203% 167.26K to 507.26K | |
| 23-Nov-21 8:22 PM View: | Theravance Biopharma, Inc. (TBPH) | 19-Nov-21 | Payment of Exercise | 1,350 | $8.36 | $11,286.00 | (< 1%) 168.61K to 167.26K | (< 1%) |
| 24-Aug-21 6:55 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Aug-21 | Payment of Exercise | 17,464 | $14.05 | $245,369.00 | (9%) 184.84K to 167.38K | (< 1%) |
| 24-May-21 6:10 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-May-21 | Payment of Exercise | 942 | $17.80 | $16,767.60 | (< 1%) 185.79K to 184.84K | 2% |
| 23-Feb-21 6:07 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Feb-21 | Payment of Exercise | 3,984 | $18.79 | $74,859.40 | (2%) 188.69K to 184.7K | 4% |
| 10-Feb-21 5:43 PM View: | Theravance Biopharma, Inc. (TBPH) | 08-Feb-21 | Grant | 65,000 | -- | -- | 53% 123.69K to 188.69K | |
| 24-Aug-20 6:24 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Aug-20 | Payment of Exercise | 4,323 | $18.22 | $78,765.10 | (3%) 127.46K to 123.14K | (3%) |
| 29-Jul-20 5:05 PM View: | Theravance Biopharma, Inc. (TBPH) | 27-Jul-20 | Grant | 20,000 | -- | -- | 19% 107.46K to 127.46K | |
| 24-Feb-20 7:08 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Feb-20 | Payment of Exercise | 7,060 | $25.90 | $182,854.00 | (6%) 113.55K to 106.49K | 28% |
| 05-Feb-20 6:58 PM View: | Theravance Biopharma, Inc. (TBPH) | 03-Feb-20 | Grant | 63,550 | -- | -- | 127% 50.0K to 113.55K | |
| 03-Jul-19 6:05 PM View: | Theravance Biopharma, Inc. (TBPH) | 01-Jul-19 | Grant | 50,000 | -- | -- | 100% 0 to 50.0K | |
| 12-Mar-19 4:15 PM View: | Acorda Therapeutics, Inc. (ACOR) | 08-Mar-19 | Grant | 9,045 | -- | -- | 137% 6.59K to 15.64K | |
| 25-Feb-19 4:15 PM View: | Acorda Therapeutics, Inc. (ACOR) | 21-Feb-19 | Payment of Exercise | 877 | $13.38 | $11,734.30 | (12%) 7.47K to 6.59K | 95% |
| 27-Dec-18 8:11 AM View: | Acorda Therapeutics, Inc. (ACOR) | 22-Dec-18 | Grant | 2,300 | -- | -- | 44% 5.17K to 7.47K | |
| 06-Dec-18 8:05 AM View: | Acorda Therapeutics, Inc. (ACOR) | 03-Dec-18 | Market Sale (Planned) | 753 | $20.56 | $15,478.40 | (13%) 5.92K to 5.17K | 96% |
| 07-Nov-18 4:05 PM View: | Acorda Therapeutics, Inc. (ACOR) | 05-Nov-18 | Payment of Exercise | 879 | $20.28 | $17,826.10 | (13%) 6.8K to 5.92K | 96% |
| 12-Sep-18 4:11 PM View: | Acorda Therapeutics, Inc. (ACOR) | 10-Sep-18 | Grant | 2,300 | -- | -- | 51% 4.5K to 6.8K | |
| 30-May-18 7:51 AM View: | Acorda Therapeutics, Inc. (ACOR) | 25-May-18 | Market Sale | 42,615 | $24.26 | $1,034,010.00 | (90%) 47.12K to 4.5K | 97% |
| 15-May-18 7:57 AM View: | Acorda Therapeutics, Inc. (ACOR) | 13-May-18 | Payment of Exercise | 3,930 | $24.35 | $95,695.50 | (8%) 51.05K to 47.12K | 97% |
| 26-Feb-18 8:29 AM View: | Acorda Therapeutics, Inc. (ACOR) | 22-Feb-18 | Grant | 5,742 | -- | -- | 13% 45.31K to 51.05K | |
| 05-Dec-17 7:40 AM View: | Acorda Therapeutics, Inc. (ACOR) | 01-Dec-17 | Market Sale (Planned) | 817 | $20.54 | $16,784.10 | (2%) 46.12K to 45.31K | 96% |
| 17-May-17 3:57 PM View: | Acorda Therapeutics, Inc. (ACOR) | 15-May-17 | Market Sale (Planned) | 7,704 | $15.75 | $121,319.00 | (14%) 53.83K to 46.12K | 95% |
| 03-Mar-17 4:34 PM View: | Acorda Therapeutics, Inc. (ACOR) | 01-Mar-17 | Grant | 4,600 | -- | -- | 9% 49.23K to 53.83K | |
| 05-Dec-16 5:09 PM View: | Acorda Therapeutics, Inc. (ACOR) | 01-Dec-16 | Market Sale (Planned) | 443 | $20.72 | $9,180.07 | (< 1%) 49.67K to 49.23K | 96% |
| 16-May-16 3:12 PM View: | Acorda Therapeutics, Inc. (ACOR) | 13-May-16 | Market Sale (Planned) | 4,860 | $26.11 | $126,885.00 | (9%) 54.53K to 49.67K | 97% |
| 03-Dec-15 4:39 PM View: | Acorda Therapeutics, Inc. (ACOR) | 01-Dec-15 | Market Sale (Planned) | 442 | $38.26 | $16,910.90 | (< 1%) 54.97K to 54.53K | 98% |
| 15-May-15 5:38 PM View: | Acorda Therapeutics, Inc. (ACOR) | 15-May-15 | Market Sale | 475 | $30.16 | $14,326.00 | (< 1%) 55.45K to 54.97K | 98% |
| 15-May-15 5:38 PM View: | Acorda Therapeutics, Inc. (ACOR) | 13-May-15 | Market Sale (Planned) | 4,304 | $29.78 | $128,168.00 | (7%) 59.75K to 55.45K | 98% |
| 06-Mar-15 6:25 PM View: | Acorda Therapeutics, Inc. (ACOR) | 04-Mar-15 | Grant | 4,215 | -- | -- | 8% 55.54K to 59.75K | |
| 15-May-14 6:29 PM View: | Acorda Therapeutics, Inc. (ACOR) | 13-May-14 | Grant | 55,536 | -- | -- | 100% 0 to 55.54K |